Compelling evidence suggests a significant role of NLRP3 inflammasome in the initiation and progression of metaflammation (i.e., metabolically-induced inflammation) and related diseases, such as obesity, T2DM, NAFLD, and atherosclerosis (16–18). Here, NLRP3 is linked to obesity due to melanocortin 4 receptor deficiency.